# Oishi Koseido Co., Ltd. – FDA Inspection, Sep 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/oishi-koseido-co-ltd/9e21866d-cca2-4a4d-aa64-3954fb5fe0ea
Source feed: FDA_Inspections

> FDA inspection 1216777 of Oishi Koseido Co., Ltd., September 01, 2023. Classification: Voluntary Action Indicated (VAI). 12 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216777
- Company Name: Oishi Koseido Co., Ltd.
- Inspection Date: 2023-09-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 12

## Related Documents

- FDA Inspection 1341740 - 2026-09-18
- FDA Inspection 1037551 - 2017-12-08
- FDA Inspection 956220 - 2016-01-29

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)

Company: https://www.keypedia.com/companies/oishi-koseido-co-ltd/07ae7f38-2728-4248-8ef1-ff0abd9a79e7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c